HEDIS Provider Quick Reference Guide. HUSKY Medical ASO (CHNCT)

Transcription

1 HEDIS Provider Quick Reference Guide HUSKY Medical ASO (CHNCT)

2 Contents Children and Adolescent Measures... 4 Measure: Well-Child Visits First 15 Months of Life (W15)... 4 Measure: Childhood Immunizations (CIS)... 5 Measure: Lead Screening in Children (LSC)... 6 Measure: Well-Child Visits 3 6 Years (W34)... 6 Measure: Weight Assessment and Counseling (WCC)... 7 Measure: Adolescent Well-Care Visit (AWC)... 7 Measure: Immunizations for Adolescents (IMA)... 8 Measure: Human Papillomavirus for Female Adolescents (HPV)... 8 Measure: Appropriate Testing in Children with Pharyngitis (CWP)... 9 Measure: Appropriate Treatment for Children with URI (URI) Adult Measures Measure: Adults Access to preventive/ambulatory Health Services (AAP) Measure: Adult BMI Assessment (ABA) Measure: Spirometry Testing in COPD Assessment (SPR) Measure: Low Back Pain (LBP) Diagnosis Specific Measures Measure: Medication Management for People with Asthma (MMA) Measure: Comprehensive Diabetes Care (CDC) Measure: Controlling High Blood Pressure (CBP) Female Specific Measures Measure: Chlamydia Screening (CHL) Measure: Cervical Cancer Screening (CCS) Measure: Non-Recommended Cervical Cancer Screening in Adolescent Females (NCS) Measure: Prenatal Care- Timeliness (PPC-Pre) Measure: Postpartum Care (PPC-Post) Measure: Breast Cancer Screening (BCS) Behavioral Measures Measure: Antidepressant Medication Management (AMM) Measure: Follow-up Care for Children Prescribed ADHD Medication (ADD) HUSKY Medical ASO (CHNCT) 2

3 Measure: Follow-up after Hospitalization for Mental Illness (FUH) Measure: Diabetes Screening for People With Schizophrenia or Bipolar Disorder Measure: Cardiovascular Monitoring for People with Cardiovascular Disease and Schizophrenia (SMC) Measure: Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) Measure: Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Measure: Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) HUSKY Medical ASO (CHNCT) 3

4 Children and Adolescent Measures Measure: Well-Child Visits First 15 Months of Life (W15) Measure : Children who turned 15 months old during the measurement year and who had at least 6 well-child visits prior to turning 15 months. Well-child visits consists of: A health and developmental history (physical and mental) A physician exam Health education/anticipatory guidance to Identify Well-Child Visits Well-Child Visits CPT: , ICD-9: V20.2, V20.3, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9 HUSKY Medical ASO (CHNCT) 4

5 Measure: Childhood Immunizations (CIS) Measure : Children 2 years of age who had the following vaccines on or before their second birthday: 4 DTaP (diphtheria, tetanus, and acellular pertussis) 3 IPV (polio) 1 MMR (measles, mumps, rubella) 3 HiB (H influenza type B) 3 Hep B (hepatitis B) 3 Hep B (hepatitis B) 1 VZV (chicken pox) 4 PCV (pneumococcal conjugate) 1 Hep A (hepatitis A) 2 or 3 RV (rotavirus) to Identify Childhood Immunizations DTaP 90698, 90700, 90721, HiB , 90698, 90721, IPV 90698, 90713, Hepatitis B 90723, 90740, 90744, 90747, MMR 90707, VZV 90710, Measles and Rubella Pneumococcal conjugate Measles Rotavirus (two-dose schedule) Mumps Rotavirus (three-dose schedule) Rubella Combination Immunizations 90669, , 90698, 90696, 90748, 90710, 90644

6 Measure: Lead Screening in Children (LSC) Measure : Children 2 years of age who had one or more capillary or venous lead blood test for lead poisoning by their second birthday. to Identify Lead Tests CPT Code Lead Tests Measure: Well-Child Visits 3 6 Years (W34) Measure : Children 3 to 6 years of age who had one more well-child visits with a PCP during the measurement year. Well-child visits consists of: A health and developmental history (physical and mental) A physical exam Health education/anticipatory guidance to Identify Well-Child Visits Well-Child Visits CPT: , , ICD-9: V20.2, V20.3, V20.31, V20.32, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9

7 Measure: Weight Assessment and Counseling (WCC) Measure : Children 3-17 years of age who had an outpatient visit with a primary care physician or OB/GYN and who had evidence of the following during the measurement year. BMI percentile documentation or BMI plotted on age appropriate growth chart (height, weight and BMI must be documented) Counseling for nutrition Counseling for physical activity *For adolescents years on the date of service, documentation of BMI value expressed as kg/m2 is acceptable. to Identify BMI, Nutrition and Physical Activity Counseling BMI Percentile ICD-9: V85.5 Counseling for Nutrition ICD-9: V65.3 Counseling for Physical Activity ICD-9: V65.41 Measure: Adolescent Well-Care Visit (AWC) Measure : Patients years of age who had one comprehensive well-care visit with a PCP or OB/GYN during the measurement year. Well-care visit consists of: A health and developmental history (physical and mental) A physical exam Health education/anticipatory guidance to Identify Well-Child Visits Well-Child Visits CPT: , , ICD-9: V20.2, V20.3, V20.31, V20.32, V70.0. V70.3, V70.5, V70.6, V70.8, V70.9

8 Measure: Immunizations for Adolescents (IMA) Measure : Children 13 years of age who received the following vaccines on or before their 13th birthday: One meningococcal vaccine One Tdap or one Td vaccine to Identify Adolescent Immunizations Meningococcal CPT: 90733, Tdap CPT: Td CPT: Tetanus CPT: Diphtheria CPT: Measure: Human Papillomavirus for Female Adolescents (HPV) Measure : Female adolescents 13 years of age who had three doses of human papillomavirus (HPV) vaccine by the 13 th birthday. to Identify HPV Vaccine HPV CPT: 90649, HUSKY Medical ASO (CHNCT) 8

9 Measure: Appropriate Testing in Children with Pharyngitis (CWP) Measure : Children 2-18 years of age diagnosed with pharyngitis and dispensed an antibiotic should have received a Group A strep test. to Identify Pharyngitis ICD-9 Acute pharyngitis 462 Acute tonsillitis 463 Streptococcal sore throat O34.0 to Strep Test CPT Strep Test 87070, 87071, 87081, 87430, , 87880

10 Measure: Appropriate Treatment for Children with URI (URI) Measure : Children 2-18 years of age diagnosed with URI should not be dispensed an antibiotic within 3 days of the diagnosis. Note: Claims/encounters with more than one diagnosis (e.g., competing diagnoses) are excluded from the measure. to Identify URI ICD-9 Acute nasopharyngitis (common cold) 460 URI 465 to Identify Competing Diagnoses ICD-9 Otitis media 382 Acute sinusitis 461 Acute pharyngitis 034.0, 462 Acute tonsillitis 463 Chronic sinusitis 473 Pneumonia Acne 706.0, 706.1

11 Adult Measures Measure: Adults Access to preventive/ambulatory Health Services (AAP) Measure : Patients 20 years and older who had an ambulatory or preventive care visit during the measurement year. to Identify Preventive/Ambulatory Health Services Office or other outpatient service CPT: , , , Preventive medicine CPT: , , , 99411, 99412, General medical examination ICD-9: V20.2, V70.0, V70.3, V70.5, V70.6, V70.8, V70.9

12 Measure: Adult BMI Assessment (ABA) Measure : Adults years of age who had an outpatient visit and whose body mass index (BMI) was documented during the measurement year or the year prior to the measurement year. to Identify BMI ICD-9 BMI less than 19, adult V85.0 BMI between 19-24, adult V85.1 BMI between 25-29, adult BMI between , adult BMI 40 and over, adult V85.21-V85.25 V85.30-V85.39 V85.41-V85.45 BMI, pediatric, <5 th percentile for age V85.51 BMI, pediatric, 5 th percentile to 85 th percentile for age V85.52 BMI, pediatric, 85 th percentile to <95 th percentile for age V85.53 BMI, pediatric, >95 th percentile for age V85.54 Documentation in the medical record must indicate the weight and BMI value, dated during the measurement year or year prior to the measurement year. For patients younger than 19 years on the date of service, documentation of BMI percentile also meets criteria: BMI percentile documented as a value (e.g., 85 th percentile) BMI percentile plotted on the age-growth chart

13 Measure: Spirometry Testing in COPD Assessment (SPR) Measure : Patients 40 years of age and older with a new diagnosis of COPD or newly active COPD, who received a spirometry testing to confirm the diagnosis in the 2 years prior to the diagnosis or within 6 months of the diagnosis. to Identify COPD ICD-9-CM Diagnosis Chronic bronchitis 491 Emphysema 492 COPD 493.2, 496 to Identify Spirometry Testing CPT Spirometry 94010, , 94060, 94070, 94375, 94620

14 Measure: Low Back Pain (LBP) Measure : Patients years of age with a new primary diagnosis of low back pain in an outpatient, or ED visit who did not have an x-ray, CT, or MRI within 28 days of the primary diagnosis. A higher score indicates appropriate treatment of low back pain (i.e., the proportion for whom imaging studies did not occur). to Identify Low Back Pain ICD-9 Low Back Pain 721.3, , , , , , , 724.2, 724.3, 724.5, 724.6, 724.7, 738.5, 739.3, 739.4, 846, to Identify Exclusions Cancer ICD , , V10 Trauma , , , , , , 929, 952, IV Drug Abuse , 304.4,

15 Diagnosis Specific Measures Measure: Medication Management for People with Asthma (MMA) Measure : The percentage of patients 5-64 years of age during the measurement year who were identified as having persistent asthma and who were dispensed an asthma controller medication during the measurement year. Patients are in the measure if they meet at least one of the following during both the measurement year and the year prior: At least one ED visit with asthma as the principal diagnosis. At least one acute inpatient claim/encounter, with asthma as the principal diagnosis. At least 4 outpatient asthma visits with asthma as one of the diagnoses and at least 2 asthma medication dispensing events. At least four asthma medication dispensing events. to Identify Asthma ICD-9 Asthma 493.0, 493.1, 493.8, Asthma Controller Medications Antiasthmatic combinations Antibody inhibitor Inhaled steroid combinations Inhaled corticosteroids Leukotriene modifiers Mast cell stabilizers Methylxanthines Prescriptions Dyphylline-guaifenesin, Guaifenesin-theophylline, Potassium iodidtheophylline Omalizumab Budesonide-formoterol, Fluticasone-salmeterol, Mometasoneformoterol Beclomethasone, Budesonide, Ciclesonide, Flunisolide, Fluticasone, CFC free, Mometasone, Triamcinolone Montelukast, Zafirlikast, Zileuton Cromolyn, Nedocromil Aminophylline, Dyphylline, Oxtriphylline, Theophylline

16 Measure: Comprehensive Diabetes Care (CDC) Measure : Adults years of age with diabetes (type 1 and type 2) who had each of the following: Hemoglobin A1c (HbA1c) testing HbA1C control (<8.0%) Eye exam (retinal or dilated) performed BP control (<140/90mmHg) Nephropathy monitoring to Identify Diabetes to Identify Diabetes to Identify HbA1c Tests to Identify Nephropathy Screening Test to Identify Eye Exam (Must be performed by optometrist or ophthalmologist) Code ICD-9: 250, 357.2, 362.0, , CPT: 83036, CPT: 82042, 82043, 82044, CPT: 67028, 67030, 67031, 67036, , 67101, 67105, 67107, 67108, 67110, 67112, 67113, 67121, 67141, 67145, 67208, 67210, 67218, 67220, 67221, 67227, 67228, 92002, 92004, 92012, 92014, 92018, 92019, 92134, , 92230, 92235, 92240, 92250, 92260, , , Measure: Controlling High Blood Pressure (CBP) Measure : Patients years of age who had a diagnosis of hypertension (HTN) and whose BP was adequately controlled (<140/90) during the measurement year (the most recent BP is used). Note: Patients are included in the measure if there was a claim/encounter with a diagnosis of hypertension prior to June 30 of the measurement year. to Identify Hypertension Hypertension ICD-9 Code 401.xx HUSKY Medical ASO (CHNCT) 16

17 Female Specific Measures Measure: Chlamydia Screening (CHL) Measure : Women years of age who were identified as sexually active and who had at least one Chlamydia test during the measurement year. to Identify Chlamydia Screening CPT Code Chlamydia Screening 87110, 87270, 87320, , Measure: Cervical Cancer Screening (CCS) Measure : Women years of age who received one or more Pap tests to screen for cervical cancer during the measurement year or the 2 years prior. Women years of age who received one or more Pap test and HPV co-testing to screen for cervical cancer during the measurement year or the 4 years prior. Exclusions: Women who had a hysterectomy with no residual cervix. *Female Adolescents ages years are not recommended to have cervical cancer screening. Exceptions are history of cervical cancer, HIV, and Immunodeficiency. to Identify Cervical Cancer Screening Code Cervical Cancer Screening CPT: , 88147, 88148, 88150, , , 88174, 88175, HCPCS: G0123, G0143-G0145, G0147, G0148, P3000, P3001 UB Revenue: 0923 HUSKY Medical ASO (CHNCT) 17

18 Measure: Non-Recommended Cervical Cancer Screening in Adolescent Females (NCS) Measure : The percentage of adolescent females years of age who were screened unnecessarily for cervical cancer. to Identify Cervical Cancer Screening Code Cervical Cancer Screening CPT: , 88147, 88148, 88150, , , 88174, 88175, HCPCS: G0123, G0143-G0145, G0147, G0148, P3000, P3001 UB Revenue: 0923

19 Measure: Prenatal Care- Timeliness (PPC-Pre) Measure : Prenatal care visit in the first trimester or as early as possible upon member request of appointment. For members newly enrolled in HUSKY Health who are pregnant, schedule visit within 42 days of enrollment. Measure looks for any visit to an OB/GYN, midwife, FP, or other PCP with one of these: Obstetric panel TORCH antibody panel Rubella antibody/titer with Rh incompatibility (ABO/Rh blood typing) Ultrasound of pregnant uterus Pregnancy-related diagnosis code Documented LMP or EDD with either a completed obstetric history or risk assessment and counseling/education. Global billing or bundling codes do not provide specific date information to count towards this measure. Please consider not using global billing or bundling codes. to Identify Prenatal Care Visits Prenatal Care Visits CPT: 59400*, 59425*, 59426*, 59510*, 59610*, 59618*, 76801, 76805, 76811, 76813, , , 80055, 86644, 86694, 86695, 86696, 86762, 86777, 86900, 86901, , , CPT II: 0500F, 0501F, 0502F ICD-9 Diagnosis: 640.x3, 641.x3, 642.x3, 643.x3, 644.x3, 645.x3, 646.x3, 647.x3, 648.x3, 649.x3, 651.x3, 652.x3, 653.x3, 654.x3, 655.x3, 565.x3, 657.x3, 658.x3, 659.x3, 678.x3, 679.x3, V22-V23, V28 *These codes are only useful if the claim indicates when prenatal care was initiated

20 Measure: Postpartum Care (PPC-Post) Measure : Postpartum care visit to an OB/GYN practitioner or midwife, family practitioner or other PCP between 21 and 56 days after delivery. A postpartum exam visit note should include: A pelvic exam, or Weight, BP, breast and abdominal evaluation, breastfeeding status incompatibility (ABO/Rh blood typing), or PP check, PP care, six week notation, or pre-printed Postpartum Care form in which information was documented during the visit Global billing or bundling codes do not provide specific date information to count towards this measure. Please consider not using global billing or bundling codes. to Identify Postpartum Visits Postpartum Visit CPT: 57170, 58300, , 88147, 88148, 88150, , , 88174, CPT II: 0503F, HCPCS: G0123, G0143-G0145, G0147, G0148, P3000, P3001 ICD-9 CM Diagnosis: v24.1, v24.2, V25.1, V72.3, V76.2 UB Rev: 0923 Measure: Breast Cancer Screening (BCS) Measure : Women years of age who had one or more mammograms during the measurement year or the year prior to the measurement year. Exclusions: Bilateral mastectomy Note: Biopsies, breast ultrasounds and MRIs do not count because HEDIS does not consider them to be appropriate primary screening methods. to Identify Breast Cancer Screening Breast Cancer Screening CPT: HCPCS: G0202, G0204, G0206 ICD-9: 87.36, UB Revenue: 0401, 0403

21 Behavioral Measures Measure: Antidepressant Medication Management (AMM) Measure : The percentage of adults 18 years of age and older who are diagnosed with a new episode of major depression and were treated with antidepressant medication; the following two rates are reported: Effective Acute Phase Treatment: the percentage of newly diagnosed and treated patients who remained on an antidepressant medication for at least 84 days (12 weeks). Effective Continuation Phase Treatment: the percentage of newly diagnosed and treated patients who remained on an antidepressant medication for at least 180 days (6 months). to Identify Major Depression ICD-9 Major Depression , , 298.0, 311 HUSKY Medical ASO (CHNCT) 21

22 Measure: Follow-up Care for Children Prescribed ADHD Medication (ADD) Measure : Patients 6-12 years old, with a new prescription for an ADHD medication who had At least one follow-up visit with practitioner with prescribing authority during the first 30 days. At least two follow-up visits within 270 days after the end of the initiation phase. to Identify Follow-up Visits Follow-up Visits CPT: , , , , , , , 99383, 99384, , , 99411, HCPCS: H0031, H0035, H0039, H2000, H2011- H2015, H2017, H2019, M0064, S9480, S9484, S9485 UB Revenue: 0510, 0513, , , , 0900, , 0907, , 0919, 0983 CPT: 90791, 90792, , 90847, 90849, 90853, 90875, With POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 20, 22, 33, 49, 50, 52, 53, 71, 72 CPT: , , 99238, 99239, With POS: 52, 53

23 Measure: Follow-up after Hospitalization for Mental Illness (FUH) Measure : Patients 6 years of age and older who were hospitalized for treatment of selected mental health disorders who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner within 7- and 30- days of discharge. to Identify Follow-up Visits Must be with Mental Health Practicioner Follow-up Visits CPT: , , , , , , , , , 99411, HCPCS: H0031, H0035, H0039, H2000, H2011-H2015, H2017, H2019, M0064, S9480, S9484, S9485 CPT: 90791, 90792, , , 90847, 90849, 90853, 90870, 90875, With POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 20, 22, 24, 33, 49, 50, 52, 53, 71 CPT: , , 99238, 99239, With POS: 52, 53

24 Measure: Diabetes Screening for People With Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) Measure : The percentage of members years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year. Identify members with schizophrenia or bipolar disorder as those who met at least one acute inpatient encounter, with any diagnosis of schizophrenia or bipolar disorder. OR At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or nonacute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. OR At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or nonacute inpatient setting, on different dates of service, with any diagnosis of bipolar disorder. AND Members glucose test or an HbA1c test performed during the measurement year to Identify Standalone Acute Inpatient w/schizophrenia or Bipolar Disorder Stand Alone Acute Inpatient with Schizophrenia or Bipolar Disorder UB Revenue: 0100, 0101, 0110, 0111, 0112, 0113, 0114, 0119, 0120, 0121, 0122, 0123, 0124, 0129, 0130, 0131, 0132, 0133, 0134, 0139, 0140, 0141, 0142, 0143, 0144, 0149, 0150, 0151, 0152, 0153, 0154, 0159, 0160, 0164, 0167, 0169, 0200, 0201, 0202, 0203, 0204, 0206, 0207, 0208, 0209, 0210, 0211, 0212, 0213, 0214, 0219, 0720, 0721, 0722, 0723, 0724, 0729, 0987 OR Bipolar Disorder ICD-9: , , , , ,

25 to Identify Acute Inpatient Encounter w/pos and w/schizophrenia or Bipolar Disorder Inpatient Encounter with Schizophrenia or Bipolar Disorder CPT: 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, 99221, 99222, 99223, 99231, 99232, 99233, 99238, 99239, 99251, 99252, 99253, 99254, 99255, 99291, 90791, 90792, 90832, POS: 21, 51 AND OR Bipolar Disorder ICD-9: , , , , , to Identify Standalone OP/PH/IOP w/schizophrenia or Bipolar Disorder At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia or Bipolar Disorder. CPT: 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215,99217, 99218, 99219, 99220, 99241, 99242, 99243, 99244, 99245, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384, 99385, 99386, 99387, 99394, 99395, 99396, 99397, 99401, 99402, 99403, 99404, 99411, OR HCPCS: H0031, H0035, H0039, H2000, H2011-H2015, H2017, H2019, M0064, S9480, S9484, S9485 OR UB Revenue: 0510, 0513, 0516, 0517, 0519, 0520, 0521, 0522, 0523, 0526, 0527, 0528, 0529, 0900, 0901, 0902, 0903, 0904, 0905, 0907, 0911, 0912, 0913, 0914, 0915, 0916, 0917, 0919, 0982, 0983 With OR Bipolar Disorder ICD-9: , , , , , HUSKY Medical ASO (CHNCT) 25

26 to Identify Visits in OP/PH/IOP w/op/ph/iop Place of Service and Diagnosis of Schizophrenia or Bipolar Disorder At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service Schizophrenia or Bipolar Disorder CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, 99221, 99222, 99223, 99231, 99232, 99233, 99238, 99239, 99251, 99252, 99253, 99254, 99255, OP POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 20, 22, 24, 33, 49, 50, 52, 53, 71, 72 AND OR Bipolar Disorder ICD-9: , , , , , to Identify ED Visits w/diagnosis of Schizophrenia or Bipolar Disorder At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service Schizophrenia CPT: 99281, 99282, 99283, 99284, UB Revenue: 0450, 0451, 0452, 0456, 0459, 0981 OR Bipolar Disorder ICD-9: , , , , , HUSKY Medical ASO (CHNCT) 26

27 to Identify BH ED Visits in ED Place of Service w/diagnosis of Schizophrenia or Bipolar Disorder At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service Schizophrenia CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 23 AND OR Bipolar Disorder ICD-9: , , , , , to Identify Standalone Non-acute Inpatient Visits w/diagnosis of Schizophrenia or Bipolar Disorder At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service Schizophrenia CPT: 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99315, 99316, 99318, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, HCPCS: T2048 UB Revenue: 0118, 0128, 0138, 0148, 0158, 0190, 0191, 0192, 0193, 0194, 0199, 0524, 0525, 0550, 0551, 0552, 0559, 0660, 0661, 0662, 0663, 0669, 1000, 1001, 1003, 1004, 1005 OR Bipolar Disorder ICD-9: , , , , ,

28 to Identify BH Non-acute Inpatient with Non-acute Place of Service and w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service Schizophrenia CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 31, 32, 56 AND HUSKY Medical ASO (CHNCT) 28

29 Measure: Cardiovascular Monitoring for People with Cardiovascular Disease and Schizophrenia (SMC) Measure : The percentage of members years of age with schizophrenia and cardiovascular disease, who had an LDL-C test during the measurement year Step 1: Identify members with schizophrenia as those who met at least one acute inpatient encounter, with any diagnosis of schizophrenia. OR At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. Step 2: Identify members from step 1 who also have Cardiovascular Disease to Identify Stand Alone Acute Inpatient Encounter w/schizophrenia At least one acute inpatient encounter, with any diagnosis of schizophrenia. UB Revenue: 0100, 0101, 0110, 0111, 0112, 0113, 0114, 0119, 0120, 0121, 0122, 0123, 0124, 0129, 0130, 0131, 0132, 0133, 0134, 0139, 0140, 0141, 0142, 0143, 0144, 0149, 0150, 0151, 0152, 0153, 0154, 0159, 0160, 0164, 0167, 0169, 0200, 0201, 0202, 0203, 0204, 0206, 0207, 0208, 0209, 0210, 0211, 0212, 0213, 0214, 0219, 0720, 0721, 0722, 0723, 0724, 0729, 0987 to Identify Acute Inpatient Encounter w/pos and w/schizophrenia At least one acute inpatient encounter, with any diagnosis of schizophrenia. CPT: 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, 99221, 99222, 99223, 99231, 99232, 99233, 99238, 99239, 99251, 99252, 99253, 99254, 99255, 99291, 90791, 90792, 90832, POS: 21, 51 AND

30 to Identify Stand Alone Outpatient/PH/IOP w/schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215,99217, 99218, 99219, 99220, 99241, 99242, 99243, 99244, 99245, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384, 99385, 99386, 99387, 99394, 99395, 99396, 99397, 99401, 99402, 99403, 99404, 99411, OR HCPCS: H0031, H0035, H0039, H2000, H2011-H2015, H2017, H2019, M0064, S9480, S9484, S9485 OR UB Revenue: 0510, 0513, 0516, 0517, 0519, 0520, 0521, 0522, 0523, 0526, 0527, 0528, 0529, 0900, 0901, 0902, 0903, 0904, 0905, 0907, 0911, 0912, 0913, 0914, 0915, 0916, 0917, 0919, 0982, 0983 With to Identify Visits in OP/PH/IOP w/op/ph/iop Place of Service and Diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, 99221, 99222, 99223, 99231, 99232, 99233, 99238, 99239, 99251, 99252, 99253, 99254, 99255, OP POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 20, 22, 24, 33, 49, 50, 52, 53, 71, 72 AND

31 to Identify ED Visits w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia.. CPT: 99281, 99282, 99283, 99284, UB Revenue: 0450, 0451, 0452, 0456, 0459, 0981 to Identify BH ED Visits in ED Place of Service w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia.. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 23 AND

32 to Identify Standalone Non-acute Inpatient Visits w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99315, 99316, 99318, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, HCPCS: T2048 UB Revenue: 0118, 0128, 0138, 0148, 0158, 0190, 0191, 0192, 0193, 0194, 0199, 0524, 0525, 0550, 0551, 0552, 0559, 0660, 0661, 0662, 0663, 0669, 1000, 1001, 1003, 1004, 1005 to Identify BH Non-acute Inpatient with Non-acute Place of Service and w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 31, 32, 56 AND

33 to Identify BH Non-acute Inpatient with Non-acute Place of Service and w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 31, 32, 56 AND

34 Measure: Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) Measure : The percentage of members years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period. Step 1: Identify members with schizophrenia as those who met at least one acute inpatient encounter, with any diagnosis of schizophrenia. OR At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. Step 2: Exclude members with a diagnosis of dementia. Did not have at least two antipsychotic medication dispensing events, with at least one of the events occurring on or between January 1 and September 30. to Identify Stand Alone Acute Inpatient Encounter w/schizophrenia At least one acute inpatient encounter, with any diagnosis of schizophrenia.. UB Revenue: 0100, 0101, 0110, 0111, 0112, 0113, 0114, 0119, 0120, 0121, 0122, 0123, 0124, 0129, 0130, 0131, 0132, 0133, 0134, 0139, 0140, 0141, 0142, 0143, 0144, 0149, 0150, 0151, 0152, 0153, 0154, 0159, 0160, 0164, 0167, 0169, 0200, 0201, 0202, 0203, 0204, 0206, 0207, 0208, 0209, 0210, 0211, 0212, 0213, 0214, 0219, 0720, 0721, 0722, 0723, 0724, 0729, 0987 to Identify Acute Inpatient Encounter w/pos and w/schizophrenia At least one acute inpatient encounter, with any diagnosis of schizophrenia. CPT: 90834, 90836, 90837, 90838, 90839, 90840, 90845, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, 99221, 99222, 99223, 99231, 99232, 99233, 99238, 99239, 99251, 99252, 99253, 99254, 99255, 99291, 90791, 90792, 90832, POS: 21, 51 AND

35 to Identify Stand Alone Outpatient/PH/IOP w/schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 99201, 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215,99217, 99218, 99219, 99220, 99241, 99242, 99243, 99244, 99245, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99384, 99385, 99386, 99387, 99394, 99395, 99396, 99397, 99401, 99402, 99403, 99404, 99411, OR HCPCS: H0031, H0035, H0039, H2000, H2011-H2015, H2017, H2019, M0064, S9480, S9484, S9485 OR UB Revenue: 0510, 0513, 0516, 0517, 0519, 0520, 0521, 0522, 0523, 0526, 0527, 0528, 0529, 0900, 0901, 0902, 0903, 0904, 0905, 0907, 0911, 0912, 0913, 0914, 0915, 0916, 0917, 0919, 0982, 0983 With to Identify Visits in OP/PH/IOP w/op/ph/iop Place of Service and Diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, 99221, 99222, 99223, 99231, 99232, 99233, 99238, 99239, 99251, 99252, 99253, 99254, 99255, OP POS: 03, 05, 07, 09, 11, 12, 13, 14, 15, 20, 22, 24, 33, 49, 50, 52, 53, 71, 72 AND HUSKY Medical ASO (CHNCT) 35

36 to Identify ED Visits w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 99281, 99282, 99283, 99284, UB Revenue: 0450, 0451, 0452, 0456, 0459, 0981 to Identify BH ED Visits in ED Place of Service w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 23 AND HUSKY Medical ASO (CHNCT) 36

37 to Identify Standalone Non-acute Inpatient Visits w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99315, 99316, 99318, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, HCPCS: T2048 UB Revenue: 0118, 0128, 0138, 0148, 0158, 0190, 0191, 0192, 0193, 0194, 0199, 0524, 0525, 0550, 0551, 0552, 0559, 0660, 0661, 0662, 0663, 0669, 1000, 1001, 1003, 1004, 1005 to Identify BH Non-acute Inpatient with Non-acute Place of Service and w/diagnosis of Schizophrenia At least two visits in an outpatient, intensive outpatient, partial hospitalization, ED or non-acute inpatient setting, on different dates of service, with any diagnosis of schizophrenia. CPT: 90791, 90792, 90832, 90833, 90834, 90836, 90837, 90838, 90847, 90849, 90853, 90867, 90868, 90869, 90870, 90875, 90876, POS: 31, 32, 56 AND HUSKY Medical ASO (CHNCT) 37

38 Measure: Use of Multiple Concurrent Antipsychotics in Children and Adolescents (APC) Measure : The percentage of children and adolescents 1 17 years of age who were on two or more concurrent antipsychotic medications. Note: A lower rate indicates better performance.

39 Measure: Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Measure : The percentage of children and adolescents 1 17 years of age who had two or more antipsychotic prescriptions and had metabolic testing. At least one test for blood glucose test or HbA1c test during the measurement year AND At least one test for LDL-C or other cholesterol test during the measurement year. Prescription First-generation antipsychotic medications Chlorpromazine HCL Fluphenazine HCL Fluphenazine decanoate Fluphenazine enanthate Haloperidol Haloperidol decanoate Haloperidol lactate Loxapine HCL Loxapine succinate Molindone HCL Perphenazine Pimozide Promazine HCL Thioridazine HCL Thiothixene Thiothixene HCL Trifluoperazine HCL Triflupromazine HCL Second generation antipsychotic medications Aripiprazole Clozapine Iloperidone Olanzapine Combinations Olanzapine-fluoxetine HCL (Symbyax) Olanzapine pamoate Paliperidone Paliperidone palmitate Quetiapine fumarate Perphenazine-amitriptyline HCL (Etrafon, Triavil [various]) Risperidone Risperidone microspheres Ziprasidone HCL Ziprasidone mesylate